Mephedrone / Cathinones

Mephedrone (4-methylmethcathinone, 4-MMC) is a powerful synthetic cathinone stimulant and entactogen that emerged as a 'legal high' substitute for MDMA and cocaine in the 2000s. It produces intense euphoria, empathy, stimulation, and sexual enhancement. CRITICAL WARNING: Mephedrone has extremely high abuse liability and compulsive redosing potential. Users frequently binge for hours or days with minimal sleep. Cardiovascular risks are severe: hypertension, tachycardia, arrhythmias. Hyperthermia common. Psychosis and extreme paranoia frequent, especially with repeated use. Often sold as MDMA, cocaine, or other drugs — users unknowingly receiving it. Commonly used in 'chemsex' scenes (sex parties involving multiple drugs). Contamination with other cathinones common. Addiction develops rapidly. Legal status varies; banned in many countries but some analogs remain legal.

How It Works

Mephedrone is a monoamine reuptake inhibitor and releaser, similar to methamphetamine. It increases dopamine, norepinephrine, and serotonin in the brain by blocking reuptake and directly releasing these neurotransmitters. The combined action produces stimulation (dopamine/norepinephrine) and entactogenic effects (serotonin). More potent dopamine action than MDMA, causing intense euphoria and compulsive redosing. The serotonin component produces empathy and emotional enhancement. Duration is short (3 hours), leading to binge patterns.

Legal Status

Controlled or banned in most countries. Schedule I in United States. Many synthetic cathinone analogs (eutylone, N-ethylpentylone, others) remain legal in some jurisdictions. Often sold as 'bath salts' or 'plant food' with 'not for human consumption' labels to circumvent regulations. Legal landscape rapidly changing.

Dosage Guide (Insufflation (nasal, most common))

Note: Doses are highly variable and unreliable. Purity and adulteration are major issues — street mephedrone often diluted with inactive fillers or contaminated with other cathinones. Most users snort multiple doses (redosing every 15-30 minutes) during binges, accumulating to 500-2000mg over hours. Oral dosing requires roughly 1.5-2x the insufflated dose for similar effect. Binge binges (3-24+ hour sessions) common, with users consuming 1-3g+ per session. IV users typically use 25-100mg per injection. Tolerance develops rapidly; escalation common within single binge session.

Organ System Impacts

cardiovascular — Dangerous

Severe hypertension and tachycardia. Heart rate commonly 120-180+ bpm. Blood pressure elevated 160/100+ mmHg. Arrhythmias and palpitations frequent. Myocardial infarction (heart attack) reported in young users. Dissecting aortic aneurysm reported. Stroke risk from hypertension. Cathinone-induced cardiomyopathy with chronic use.

neurological — Dangerous

Intense stimulation and dopaminergic activation. Acute psychosis common with repeated dosing. Paranoia and extreme anxiety. Seizures possible. Serotonin syndrome from serotonergic effects. Long-term chronic use associated with cognitive decline, memory impairment, attention deficits.

ocular — Low

Pupil dilation (mydriasis). Blurred vision. Visual hallucinations possible. No long-term ocular damage documented but acute effects impair vision.

dermatological — Moderate

Profuse sweating. Skin flushing. Severe hyperhidrosis (excessive sweating). Dehydration from fluid loss. Injection-related complications: abscesses, infections, scarring, track marks. Skin picking from stimulant-induced compulsive behavior.

respiratory — Low

Rapid, shallow breathing. Hyperventilation possible from anxiety. Shortness of breath. No direct respiratory depression but indirect effects from anxiety/panic. Inhalation injury from smoking (not typical route).

hepatic — Low

Limited hepatotoxicity data specific to mephedrone. Liver may be stressed by intense metabolism and sympathomimetic effects. No specific documented liver damage pattern but hepatic dysfunction possible with chronic heavy use.

hematological — Low

No specific hematological effects documented. Anemia possible with chronic abuse and poor nutrition. Infection-related complications from IV use common.

renal — Dangerous

Acute kidney injury from rhabdomyolysis (muscle breakdown during intense physical activity and seizures). Acute tubular necrosis from myoglobinuria. Severe dehydration stresses kidneys. Hypertension damages renal vasculature. Chronic use may lead to chronic kidney disease.

gastrointestinal — Moderate

Complete loss of appetite. Nausea and vomiting. Severe dehydration from stimulant use and sweating. Bruxism (teeth grinding) from stimulation. Users often don't eat for 12-24+ hours during binges. Malnutrition from chronic abuse.

musculoskeletal — Dangerous

Rhabdomyolysis from extreme physical exertion during intoxication and from stimulant-induced muscle breakdown. Intense muscle pain, myoglobinuria, kidney failure from muscle breakdown. Muscle hypertension and rigidity. Long-term muscle damage from repeated rhabdomyolysis episodes. Seizures cause additional muscle damage.

Effects

Desired Effects

• Intense euphoria and mood elevation
• Extreme stimulation and energy
• Increased sociability and empathy
• Sexual enhancement and arousal
• Increased confidence and talkativeness
• Visual and auditory enhancements
• Empathogenic and entactogenic effects
• Sense of well-being and connection

Negative Effects

• Severe anxiety and panic
• Paranoia and persecution complex
• Extreme irritability and aggression
• Agitation and restlessness
• Confusion and disorientation
• Poor decision-making
• Compulsive redosing
• Intrusive thoughts
• Emotional dysregulation between doses

Rare but Serious

• Acute psychosis
• Severe hypertension and hypertensive crisis
• Cardiac arrhythmias and heart attack
• Hyperthermia and heat stroke
• Severe dehydration
• Seizures
• Intracerebral hemorrhage (stroke)
• Acute kidney injury
• Rhabdomyolysis from extreme physical activity
• Serotonin syndrome
• Death from cardiac or neurological causes

Drug Interactions

Detection Times

Mephedrone is not on standard drug panels. May cause false positives on amphetamine assays.

Urine

Requires specific testing. May cross-react with amphetamine assays. Detection window: up to 4 days.

Blood

Short blood detection window. Detection window: up to 2 days.

Hair

Hair testing can detect mephedrone. Detection window: up to 90 days.

Harm Reduction Tips

• Never inject. IV use dramatically increases cardiovascular risk, overdose risk, infection risk, and addiction potential.

• Limit binges. Single-use preferred; if binging, limit to <4 hours and <500mg total. 24-hour binges or 1g+ sessions carry extreme overdose risk.

• Never use alone. Use with trusted people who can monitor for medical emergencies and call help if needed.

• Maintain proper temperature regulation. Do not exert physically; do not dance intensely. Hyperthermia combined with physical exertion causes rhabdomyolysis and heat stroke.

• Do not combine with alcohol or other depressants. Do not combine with SSRIs/MAOIs (serotonin syndrome risk).

• Never drive or operate machinery. Impaired judgment, poor reaction time, and possible paranoia make this extremely dangerous.

• If use cannot be avoided: Assume unknown provenance. Street 'mephedrone' frequently sold as other drugs or adulterated with other cathinones. Test if possible with reagent tests though results are not definitive.

• Start with lowest possible dose (5-10mg insufflated). Do not escalate. Do not redose impulsively.

• Monitor vital signs: heart rate, blood pressure, temperature. Hypertension >160/100 and tachycardia >140 are warning signs. Hyperthermia >103F is emergency.

• Stay hydrated but do not over-hydrate (hyponatremia risk documented with stimulant use, especially in hot environments like dance clubs/raves).

• Eat and drink regularly if possible despite appetite loss. Malnutrition and severe dehydration are risks.

• Avoid stimulant combinations: no cocaine, methamphetamine, other cathinones. Absolutely avoid MDMA if substance is mephedrone (often misrepresented).

• ABSOLUTE BEST PRACTICE: Do not use mephedrone. The compulsive redosing potential and cardiovascular risks are extreme.

• Set redosing boundaries BEFORE use and stick to them. Users frequently ignore boundaries due to compulsive nature.

• Avoid insufflation route if possible. Oral route has longer duration, reducing redosing frequency. Nasal damage from repeated insufflation is severe.

• Allow extensive recovery time between uses (weeks-months). Do not use more than once per month. Tolerance and addiction develop extremely rapidly.

• Be aware of compulsive redosing drive. This drug has one of the highest abuse potential profiles. Binge patterns are the norm.

• Monitor for signs of addiction: inability to limit use, compulsive redosing despite intent not to, continued use despite negative consequences.

• Seek professional help if dependent. Withdrawal is psychologically severe (extreme dysphoria, anhedonia, anxiety) and relapse risk is very high.

Withdrawal Symptoms

Severity: Moderate

Crash: 1-2 days. Acute withdrawal: 3-7 days. Psychological symptoms: 2-4 weeks. Cravings may persist longer.

Physical

• Fatigue
• Nasal congestion and damage (if insufflated)
• Appetite changes
• Headaches

Psychological

• Depression
• Cravings (can be intense)
• Anxiety
• Irritability
• Insomnia
• Anhedonia
• Difficulty concentrating

Emergency Information

Call 911 If:

• Chest pain or pressure
• Difficulty breathing
• Severe hypertension (>180/120 mmHg) with symptoms
• Severe tachycardia (>150 bpm) with symptoms
• Severe hyperthermia (>104F / 40C)
• Seizures
• Loss of consciousness
• Severe agitation lasting >15 minutes
• Acute psychosis or violent behavior
• Severe muscle pain with dark urine (rhabdomyolysis)
• Severe headache with hypertension
• Any concern about overdose or medical emergency

Warning Signs

• Severe hypertension (>180/120 mmHg) with headache
• Severe tachycardia (heart rate >150 bpm)
• Chest pain or pressure (signs of cardiac event)
• Difficulty breathing or shortness of breath
• Severe hyperthermia (body temp >104F / 40C)
• Seizures or convulsions
• Severe agitation or violent behavior
• Acute psychosis or extreme paranoia
• Severe dehydration and electrolyte disturbance
• Loss of consciousness
• Severe muscle pain and dark urine (rhabdomyolysis signs)
• Uncontrollable jaw clenching
• Disorientation and confusion

What To Do

1. Call 911 immediately if any serious symptoms present.
2. Move person to safe location.
3. Cool if hyperthermic: ice packs, cool water, remove excess clothing.
4. Monitor vital signs: heart rate, blood pressure, temperature, breathing.
5. Have person sit down if standing. Monitor for fainting.
6. Stay calm and reassured; speak in calm tone.
7. Do not physically restrain unless necessary for safety.
8. Place in recovery position if unconscious; monitor airway.
9. If seizing: protect from injury, move away dangerous objects, time duration.
10. Have medical history and substance information ready for paramedics.
11. Note: Naloxone (Narcan) does not help mephedrone overdose.
12. Do not leave person alone.